aluminum sulfate has been researched along with Melanoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia, M; Groshen, SL; Hamid, O; Scotland, R; Sian, S; Solomon, JC; Weber, JS; Ye, W | 1 |
| Abeles, G; Bystryn, JC; Chen, D; Oratz, R; Schultz, N; Zeleniuch-Jacquotte, A | 1 |
| Cookson, S; Dalgleish, AG; Darling, D; Farzaneh, F; Fraziano, M; Knight, BC; Marriott, JB; Morrow, WJ; Souberbielle, BE | 1 |
| Bhattachary-Chatterjee, M; Chakraborty, M; Chatterjee, SK; Das, R; Foon, KA; Nath Baral, R; Zeytin, H | 1 |
| Bystryn, JC; Golomb, FM; Harris, MN; Oratz, R; Roses, DF; Speyer, JL | 1 |
1 review(s) available for aluminum sulfate and Melanoma
| Article | Year |
|---|---|
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Epitopes; Evaluation Studies as Topic; Gangliosides; Glycolipids; Glycoproteins; Humans; Immunization; Leukemia-Lymphoma, Adult T-Cell; Lipid Droplets; Melanoma; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Mimicry; Neoplasms; Neoplasms, Experimental; Treatment Outcome | 2000 |
3 trial(s) available for aluminum sulfate and Melanoma
| Article | Year |
|---|---|
Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: correlation with time to relapse in patients with resected high-risk disease.
Topics: Aged; Alum Compounds; Antineoplastic Agents; Cancer Vaccines; Female; Humans; Interleukin-12; Male; Melanoma; Middle Aged; Recurrence; Skin Neoplasms; Time Factors; Treatment Outcome; Vaccines, Subunit | 2007 |
Effect of DETOX as an adjuvant for melanoma vaccine.
Topics: Adjuvants, Immunologic; Adult; Aged; Alum Compounds; Antibodies, Neoplasm; Antigens, Neoplasm; Cell Wall Skeleton; Drug Synergism; Female; Humans; Hypersensitivity, Delayed; Lipid A; Male; Melanoma; Melanoma-Specific Antigens; Middle Aged; Neoplasm Proteins | 1995 |
Counterpoint. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Epitopes; Evaluation Studies as Topic; Gangliosides; Glycolipids; Glycoproteins; Humans; Immunization; Leukemia-Lymphoma, Adult T-Cell; Lipid Droplets; Melanoma; Mice; Mice, Inbred C57BL; Models, Immunological; Molecular Mimicry; Neoplasms; Neoplasms, Experimental; Treatment Outcome | 2000 |
2 other study(ies) available for aluminum sulfate and Melanoma
| Article | Year |
|---|---|
Comparison of IL-2- and IL-4-transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine.
Topics: Alum Compounds; Animals; Cancer Vaccines; Cell Line; Female; Freund's Adjuvant; Interleukin-2; Interleukin-4; Melanoma; Mice; Mice, Inbred C57BL; Oils; Transfection; Tumor Cells, Cultured; Vaccination; Vaccines, DNA | 1996 |
Immunogenicity of a polyvalent melanoma antigen vaccine in humans.
Topics: Adult; Aged; Alum Compounds; Aluminum; Antibody Formation; Antigens, Neoplasm; Cyclophosphamide; Humans; Immunity, Cellular; Immunization Schedule; Melanoma; Middle Aged; Sulfates; Vaccines | 1988 |